Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anticoagulants | 23 | 2025 | 511 | 6.340 |
Why?
|
| Atrial Fibrillation | 15 | 2025 | 854 | 3.800 |
Why?
|
| Venous Thromboembolism | 7 | 2020 | 147 | 2.650 |
Why?
|
| Pharmacists | 6 | 2023 | 129 | 2.510 |
Why?
|
| Stroke | 10 | 2025 | 1196 | 2.040 |
Why?
|
| Long-Term Care | 5 | 2021 | 177 | 1.710 |
Why?
|
| Postoperative Complications | 7 | 2022 | 1301 | 1.660 |
Why?
|
| Arthroplasty, Replacement, Hip | 5 | 2020 | 74 | 1.590 |
Why?
|
| Frailty | 4 | 2022 | 125 | 1.520 |
Why?
|
| Arthroplasty, Replacement, Knee | 5 | 2020 | 129 | 1.440 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2023 | 788 | 1.350 |
Why?
|
| Hospitalization | 9 | 2024 | 1368 | 1.200 |
Why?
|
| Homes for the Aged | 2 | 2021 | 161 | 1.190 |
Why?
|
| Cardiologists | 2 | 2019 | 28 | 1.180 |
Why?
|
| Nursing Homes | 4 | 2021 | 672 | 1.110 |
Why?
|
| Practice Patterns, Physicians' | 4 | 2020 | 708 | 1.070 |
Why?
|
| Surgical Procedures, Operative | 2 | 2020 | 142 | 1.050 |
Why?
|
| Electronic Health Records | 5 | 2023 | 368 | 1.050 |
Why?
|
| Activities of Daily Living | 4 | 2021 | 293 | 1.010 |
Why?
|
| Decision Support Techniques | 3 | 2020 | 192 | 0.940 |
Why?
|
| Medically Uninsured | 3 | 2016 | 41 | 0.930 |
Why?
|
| Health Personnel | 2 | 2020 | 389 | 0.930 |
Why?
|
| Aged | 26 | 2025 | 14662 | 0.890 |
Why?
|
| Health Care Reform | 5 | 2016 | 88 | 0.800 |
Why?
|
| Drug Utilization | 4 | 2020 | 208 | 0.790 |
Why?
|
| Preoperative Care | 3 | 2022 | 199 | 0.780 |
Why?
|
| Pharmaceutical Services | 1 | 2023 | 33 | 0.770 |
Why?
|
| Humans | 48 | 2025 | 64283 | 0.740 |
Why?
|
| Geriatric Assessment | 3 | 2021 | 160 | 0.740 |
Why?
|
| Risk Factors | 13 | 2025 | 5341 | 0.720 |
Why?
|
| Disability Evaluation | 3 | 2017 | 218 | 0.680 |
Why?
|
| House Calls | 1 | 2020 | 23 | 0.660 |
Why?
|
| Hemorrhage | 5 | 2025 | 275 | 0.660 |
Why?
|
| Warfarin | 3 | 2025 | 122 | 0.650 |
Why?
|
| Patient Transfer | 1 | 2020 | 92 | 0.620 |
Why?
|
| Healthcare Disparities | 3 | 2021 | 374 | 0.620 |
Why?
|
| Medical Order Entry Systems | 1 | 2020 | 42 | 0.620 |
Why?
|
| Electronic Mail | 1 | 2020 | 47 | 0.620 |
Why?
|
| Aged, 80 and over | 13 | 2025 | 5528 | 0.620 |
Why?
|
| Insurance Coverage | 3 | 2015 | 99 | 0.600 |
Why?
|
| Reminder Systems | 1 | 2020 | 75 | 0.600 |
Why?
|
| Documentation | 1 | 2020 | 127 | 0.590 |
Why?
|
| Administration, Oral | 6 | 2023 | 374 | 0.580 |
Why?
|
| Continuity of Patient Care | 1 | 2020 | 174 | 0.560 |
Why?
|
| Male | 25 | 2025 | 30322 | 0.560 |
Why?
|
| Self Report | 2 | 2017 | 388 | 0.550 |
Why?
|
| Frail Elderly | 2 | 2021 | 107 | 0.550 |
Why?
|
| Physicians, Primary Care | 1 | 2018 | 79 | 0.540 |
Why?
|
| Severity of Illness Index | 3 | 2020 | 1561 | 0.530 |
Why?
|
| Referral and Consultation | 1 | 2020 | 428 | 0.520 |
Why?
|
| Female | 25 | 2025 | 33382 | 0.510 |
Why?
|
| Factor Xa Inhibitors | 3 | 2023 | 37 | 0.510 |
Why?
|
| Risk Assessment | 6 | 2021 | 2048 | 0.500 |
Why?
|
| Quality of Health Care | 1 | 2020 | 526 | 0.500 |
Why?
|
| Veterans | 2 | 2016 | 780 | 0.500 |
Why?
|
| Patient Education as Topic | 1 | 2020 | 478 | 0.490 |
Why?
|
| Guideline Adherence | 1 | 2018 | 306 | 0.480 |
Why?
|
| Massachusetts | 9 | 2025 | 2096 | 0.460 |
Why?
|
| Quality Improvement | 1 | 2018 | 455 | 0.410 |
Why?
|
| Middle Aged | 15 | 2024 | 17921 | 0.400 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2014 | 146 | 0.380 |
Why?
|
| Venous Thrombosis | 1 | 2013 | 112 | 0.360 |
Why?
|
| Medication Errors | 2 | 2023 | 109 | 0.360 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 1118 | 0.350 |
Why?
|
| Age Factors | 5 | 2021 | 1570 | 0.330 |
Why?
|
| Health Services Accessibility | 3 | 2015 | 575 | 0.320 |
Why?
|
| Treatment Outcome | 6 | 2021 | 5696 | 0.310 |
Why?
|
| Clinical Decision-Making | 2 | 2021 | 163 | 0.300 |
Why?
|
| Walking | 2 | 2022 | 240 | 0.300 |
Why?
|
| Ambulatory Care | 2 | 2023 | 317 | 0.300 |
Why?
|
| Transferrin | 1 | 2009 | 70 | 0.290 |
Why?
|
| Pressure Ulcer | 1 | 2008 | 34 | 0.280 |
Why?
|
| Comorbidity | 3 | 2021 | 1119 | 0.280 |
Why?
|
| United States | 9 | 2024 | 7923 | 0.280 |
Why?
|
| Patient Participation | 2 | 2020 | 232 | 0.270 |
Why?
|
| Patient Selection | 2 | 2020 | 487 | 0.270 |
Why?
|
| Wound Healing | 1 | 2008 | 192 | 0.260 |
Why?
|
| Foot Diseases | 1 | 2007 | 15 | 0.260 |
Why?
|
| Osteomyelitis | 1 | 2007 | 24 | 0.250 |
Why?
|
| Computer Simulation | 1 | 2009 | 482 | 0.250 |
Why?
|
| Cost-Benefit Analysis | 3 | 2016 | 318 | 0.250 |
Why?
|
| Time Factors | 4 | 2021 | 3725 | 0.240 |
Why?
|
| Alcoholism | 1 | 2009 | 323 | 0.240 |
Why?
|
| Quality Indicators, Health Care | 1 | 2008 | 335 | 0.230 |
Why?
|
| Retrospective Studies | 5 | 2024 | 6740 | 0.230 |
Why?
|
| Breast Neoplasms | 1 | 2014 | 1213 | 0.220 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 726 | 0.220 |
Why?
|
| Cost of Illness | 1 | 2025 | 169 | 0.220 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2024 | 26 | 0.210 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2025 | 147 | 0.210 |
Why?
|
| Blood Coagulation | 2 | 2022 | 39 | 0.210 |
Why?
|
| Mass Screening | 1 | 2009 | 693 | 0.200 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2016 | 67 | 0.200 |
Why?
|
| Checklist | 1 | 2023 | 75 | 0.190 |
Why?
|
| Pulmonary Embolism | 1 | 2024 | 175 | 0.180 |
Why?
|
| Medication Adherence | 1 | 2023 | 205 | 0.170 |
Why?
|
| Medication Systems | 1 | 2021 | 17 | 0.170 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2022 | 161 | 0.170 |
Why?
|
| Prospective Studies | 3 | 2021 | 3318 | 0.170 |
Why?
|
| Preoperative Period | 1 | 2020 | 67 | 0.170 |
Why?
|
| Advance Care Planning | 1 | 2021 | 66 | 0.160 |
Why?
|
| Validation Studies as Topic | 1 | 2020 | 20 | 0.160 |
Why?
|
| Polypharmacy | 1 | 2020 | 61 | 0.160 |
Why?
|
| Medicare | 2 | 2021 | 611 | 0.160 |
Why?
|
| Mobility Limitation | 1 | 2020 | 49 | 0.150 |
Why?
|
| Knowledge | 1 | 2019 | 31 | 0.150 |
Why?
|
| Databases, Factual | 2 | 2020 | 856 | 0.150 |
Why?
|
| Primary Health Care | 2 | 2019 | 711 | 0.150 |
Why?
|
| Self Concept | 1 | 2019 | 113 | 0.150 |
Why?
|
| Cohort Studies | 3 | 2025 | 2605 | 0.150 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2021 | 145 | 0.150 |
Why?
|
| Safety-net Providers | 2 | 2016 | 30 | 0.150 |
Why?
|
| Cardiology | 1 | 2021 | 170 | 0.150 |
Why?
|
| Fibrinolytic Agents | 1 | 2020 | 173 | 0.150 |
Why?
|
| Home Care Services | 1 | 2020 | 98 | 0.150 |
Why?
|
| Accidental Falls | 1 | 2020 | 125 | 0.150 |
Why?
|
| Machine Learning | 1 | 2020 | 184 | 0.140 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2018 | 73 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2007 | 2218 | 0.130 |
Why?
|
| Surveys and Questionnaires | 2 | 2019 | 2738 | 0.130 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1131 | 0.130 |
Why?
|
| Models, Econometric | 1 | 2016 | 14 | 0.120 |
Why?
|
| Markov Chains | 1 | 2016 | 37 | 0.120 |
Why?
|
| Feasibility Studies | 1 | 2018 | 577 | 0.120 |
Why?
|
| Patient Discharge | 1 | 2020 | 507 | 0.120 |
Why?
|
| Adult | 5 | 2020 | 17134 | 0.120 |
Why?
|
| Cognitive Dysfunction | 1 | 2020 | 344 | 0.120 |
Why?
|
| Gait | 1 | 2016 | 120 | 0.110 |
Why?
|
| Intracranial Hemorrhages | 1 | 2015 | 68 | 0.110 |
Why?
|
| Attitude of Health Personnel | 1 | 2020 | 620 | 0.110 |
Why?
|
| Arthroplasty, Replacement | 1 | 2015 | 17 | 0.110 |
Why?
|
| Pilot Projects | 1 | 2018 | 1020 | 0.110 |
Why?
|
| Reoperation | 1 | 2016 | 292 | 0.110 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 771 | 0.110 |
Why?
|
| Analgesics, Opioid | 2 | 2010 | 531 | 0.110 |
Why?
|
| Length of Stay | 1 | 2017 | 819 | 0.100 |
Why?
|
| Young Adult | 3 | 2015 | 4781 | 0.100 |
Why?
|
| Thrombosis | 1 | 2015 | 198 | 0.100 |
Why?
|
| Adolescent | 3 | 2015 | 6305 | 0.100 |
Why?
|
| Early Detection of Cancer | 1 | 2014 | 321 | 0.080 |
Why?
|
| Urinalysis | 1 | 2010 | 38 | 0.080 |
Why?
|
| Health Status | 1 | 2013 | 447 | 0.080 |
Why?
|
| Poverty | 1 | 2012 | 299 | 0.080 |
Why?
|
| Logistic Models | 1 | 2013 | 1270 | 0.080 |
Why?
|
| Prevalence | 2 | 2025 | 1407 | 0.080 |
Why?
|
| Decision Trees | 1 | 2009 | 50 | 0.080 |
Why?
|
| Review Literature as Topic | 1 | 2009 | 39 | 0.070 |
Why?
|
| Dihydroergotamine | 1 | 2008 | 1 | 0.070 |
Why?
|
| Meperidine | 1 | 2008 | 5 | 0.070 |
Why?
|
| Ketorolac | 1 | 2008 | 13 | 0.070 |
Why?
|
| Drug Monitoring | 1 | 2010 | 206 | 0.070 |
Why?
|
| Paralysis | 1 | 2008 | 17 | 0.070 |
Why?
|
| Terminally Ill | 1 | 2008 | 17 | 0.070 |
Why?
|
| Drug Prescriptions | 2 | 2020 | 170 | 0.070 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2008 | 36 | 0.070 |
Why?
|
| Migraine Disorders | 1 | 2008 | 42 | 0.070 |
Why?
|
| Pain | 1 | 2010 | 407 | 0.070 |
Why?
|
| Leukocyte Count | 1 | 2007 | 99 | 0.060 |
Why?
|
| Technetium | 1 | 2007 | 68 | 0.060 |
Why?
|
| Radionuclide Imaging | 1 | 2007 | 128 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 205 | 0.060 |
Why?
|
| Diabetes Complications | 1 | 2007 | 106 | 0.060 |
Why?
|
| Sex Factors | 1 | 2008 | 980 | 0.060 |
Why?
|
| Glomerular Filtration Rate | 1 | 2025 | 120 | 0.060 |
Why?
|
| Radiography | 1 | 2007 | 553 | 0.060 |
Why?
|
| Odds Ratio | 1 | 2007 | 759 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 1164 | 0.050 |
Why?
|
| Biomarkers | 1 | 2009 | 1431 | 0.050 |
Why?
|
| Heparin | 1 | 2024 | 116 | 0.050 |
Why?
|
| Opioid-Related Disorders | 1 | 2010 | 513 | 0.050 |
Why?
|
| Acute Disease | 1 | 2024 | 671 | 0.050 |
Why?
|
| Socioeconomic Factors | 2 | 2015 | 788 | 0.040 |
Why?
|
| Natural Language Processing | 1 | 2021 | 47 | 0.040 |
Why?
|
| Eligibility Determination | 1 | 2020 | 36 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2021 | 330 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2021 | 271 | 0.040 |
Why?
|
| Language | 1 | 2021 | 150 | 0.040 |
Why?
|
| Respiratory Insufficiency | 1 | 2021 | 154 | 0.040 |
Why?
|
| Patient Satisfaction | 1 | 2022 | 439 | 0.040 |
Why?
|
| Focus Groups | 1 | 2020 | 310 | 0.040 |
Why?
|
| Sepsis | 1 | 2021 | 290 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2015 | 77 | 0.030 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2019 | 555 | 0.030 |
Why?
|
| Prognosis | 1 | 2020 | 1769 | 0.030 |
Why?
|
| Global Health | 1 | 2015 | 183 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2015 | 498 | 0.030 |
Why?
|
| Health Services | 1 | 2012 | 82 | 0.020 |
Why?
|
| Incidence | 1 | 2015 | 1385 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2010 | 756 | 0.020 |
Why?
|